1. Medtech Insight
  2. >>Policy & Regulation

Device Exec Charged With COVID-19 Securities Fraud

 
• By Elizabeth Orr

The CEO allegedly falsely told investors that the company was closing in on FDA clearance for a rapid-detection COVID-19 test.

Lady justice, themis, statue of justice on books background.

A diagnostics company executive is facing federal fraud charges for allegedly bilking investors out of millions by falsely stating that the company was developing a breakthrough test for COVID-19, the US Department of Justice announced recently.

Keith Berman, CEO of Decision Diagnostics Inc., was charged with one count of securities fraud and one count of making...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Policy & Regulation

FDA Blocks Some Olympus Endoscopes From Entering US

 
• By Brian Bossetta

After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.

UK Trails NHS 10-Year Plan With Launch Imminent

 
• By Ashley Yeo

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.

New EU Rules Limit Chinese Participation In Medtech Procurement

 
• By Amanda Maxwell

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.